Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LAB
FechaHoraFuenteTítuloSímboloCompañía
03/06/202416:20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
03/06/202416:19Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LABStandard BioTools Inc
03/06/202405:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
29/05/202415:34Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:LABStandard BioTools Inc
28/05/202419:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
28/05/202415:01GlobeNewswire Inc.Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan CustomersNASDAQ:LABStandard BioTools Inc
22/05/202415:01GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
21/05/202416:16Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:LABStandard BioTools Inc
21/05/202416:15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsNASDAQ:LABStandard BioTools Inc
20/05/202407:00GlobeNewswire Inc.Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LABStandard BioTools Inc
20/05/202405:03Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:LABStandard BioTools Inc
10/05/202416:16Edgar (US Regulatory)Form PREC14A - Preliminary proxy statements, contested solicitationsNASDAQ:LABStandard BioTools Inc
09/05/202415:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABStandard BioTools Inc
08/05/202415:01GlobeNewswire Inc.Standard BioTools Reports First Quarter 2024 Financial ResultsNASDAQ:LABStandard BioTools Inc
25/04/202407:01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
25/04/202407:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
08/04/202407:00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
03/04/202415:01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
18/03/202407:12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
28/02/202415:01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
26/02/202415:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
26/02/202407:00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
14/02/202414:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
14/02/202407:30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
07/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
07/02/202407:30GlobeNewswire Inc.Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineNASDAQ:LABStandard BioTools Inc
02/02/202415:49Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LABStandard BioTools Inc
19/01/202416:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
19/01/202416:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
19/01/202415:33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB